Patent · US Active

Antisense IAP nucleobase oligomers and uses thereof

US7638497B2 · kind B2 · utility

0Cited by
36References
44Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2006
Grant dateDec 29, 2009
Priority date
Expiry dateJun 30, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/53
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention features nucleobase oligomers that hybridize to IAP polynucleotide, and methods for using them to enhance apoptosis and treat proliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.